Although major pharmaceutical companies have fallen in line with President Donald Trump’s “most favored nation” (MFN) drug pricing agenda, the specifics of their negotiated concessions and the actu | ...

In an effort to battle against what members feel is an existential threat to their businesses, a group of 10 domestic biotech companies has launched the Midsized Biotech Alliance of America (MBAA) ...

Experts unpacked MFN drug pricing, expired ACA subsidies, and IRA fallout for community oncology in a recent webinar. The panelists were Lindsay Bealor Greenleaf, JD, MBA, head of market access policy ...

A strong MFN law could be a meaningful step toward bringing U.S. prices in line with those paid by other high-income countries, says Patients for Affordable Drugs Now.

The Centers for Medicare & Medicaid Services (CMS) in the US has extended the deadline for companies to take part in its ...

The implementation of the Most Favored Nation (MFN) pricing and the introduction of the GENEROUS model in U.S. Medicaid present opportunities for pharmaceutical companies to align with international ...

Denmark and Sweden are assessing how Trump’s 'Most Favoured Nation' push is affecting medicine access, now and long-term, despite safeguards in their value-based models ...

OptimizeRx Corp OPRX shares are tumbling on Friday as the company faces increased market volatility and uncertainty surrounding Most Favored Nation (MFN) pricing. Earnings Exceed Expectations The ...

Alice Valdur Curran joined the Pharmaceutical Executive Podcast to discuss the ongoing strategizing for MFN pricing in the pharma industry. With the launch of TrumpRx, the industry has a better idea ...

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. "MFN reinforces the worst incentives in 340B, shifts costs ...

Pharmaceutical research and development (R&D) is unlikely to be significantly impacted by most favored nation (MFN) pricing, according to industry experts. The US bears the highest drug costs globally ...